Citation: Gosar A, Jadhav S, Patil V, Folane S, Jadkar A, et al. Development and validation of new analytical method for the determination of particle size distribution in glimepiride using laser based particle size analyzer ( 
Introduction
Glimepiride is a white to yellowish-white, odorless powder and is practically insoluble in water. Glimepiride acts as an insulin secretagogue and it lowers blood sugar by stimulating the release of insulin by pancreatic beta cells and by inducing increased activity of intracellular insulin receptors [1] . Glimepiride chemically, is 3-ethyl-4-methyl-N-[2-[4-[(4-methylcyclohexyl)carbamoyllsulfamoyl] phenyl] ethyl]-2-oxo-5H-pyrrole-1-carboxamide is a third generation sulfonylurea derivative which is commonly used in the treatment of non-insulin dependent Type 2 diabetes mellitus [2] [3] [4] [5] . Glimepiride, marked under the trade name Amaryl, is the first line medication for the treatment of type-2 diabetes mellitus [6] [7] [8] .
Relative bioavailability, extended-released along with bioequivalence and immediate released is related to particle size of Glimepiride [9] [10] [11] [12] . Literature survey done for Particle size distribution method for Glimepiride and found that particle size determination method is not available. Therefore, study was carried out to develop a method to determine particle size distribution of Glimepiride by Particle size analyzer and further validation of the method, was carried out.
Materials and Reagent
Reagents Triton x-100, water and Glimepiride was obtained from Indoco Remedies Ltd, Navi Mumbai, India.
Instrumentation
Particle size analyzer system of make Malvern and model is 2000 consists of Dry Scirocco 2000 and wet Hydro2000S accessories.
Results and Discussion

Analytical method development
The main goal was to develop method to obtain the most stable, reproducible, reliable method. Various dispersant were tried for the Glimepiride on the basis of solubility. Water is found well suitable dispersant to develop method for determination of particle size distribution of Glimepiride. Various trial were taken during method development as mention below, Glimepiride solubility within a suitable solvent system a critical role in particle size wet method development since sample preparation is play vital role. with the help of a cleaned spatula and carried out the analysis The obscuration values are well within the limit and also weighted residual is less than 1%. Hence, proceeded for next trial by changing the feed rate 45% to check the effect on particle size. Various trials were taken by changing instrumental parameters. All method parameters were kept as per above only changed in sonication time 50 Sec. and performed the analysis. The obscuration is well within limit it is proved that there is no any effect of sonication time on particle size, Hence, preceded for next trial by changing stirrer speed check the effect on particle size. The obscuration values are well within the limit, from the obtained results there is negligible effect on the particle size by decreased in stirrer speed. 
Method validation
The validation work was conducted according to the ICH (International Conference on Harmonization) guidelines Q2R1. The method validation parameters include Precision, Intermediate Precision, Robustness and Batch Analysis.
Method Validation Parameters
Method precision Procedure: Determined the particle size of six precision samples as per above method and recorded the particle size for d(0.1), d(0.5) and d(0.9) in Table 3 and similarly, calculated cumulative average and cumulative percent relative standard deviation for particle size at d Table 3 : Robustness-1 (Change in stirrer speed to 1800 rpm). Table 4 and similarly, calculated cumulative average and cumulative percent relative standard deviation for particle size at d (10) Table 4 : Robustness-2 (Change in stirrer speed to 2200 rpm). Table 5 and Similarly, calculated cumulative average and cumulative percent relative standard deviation for particle size at d (10) Table 5 : Robustness-3 (Change in Obscuration range to 10-20%). Table 6 and similarly, calculated cumulative average and cumulative percent relative standard deviation for particle size at d (10) Table 6 : Robustness-4 (Change in Obscuration range to 20-30%). Table 7 and similarly, calculated cumulative average and cumulative percent relative standard deviation for particle size at d ( Citation: Gosar A, Jadhav S, Patil V, Folane S, Jadkar A, et al. Development and validation of new analytical method for the determination of particle size distribution in glimepiride using laser based particle size analyzer (2019) Edelweiss Appli Sci Table 7 : Robustness -5 (Change in sample measurement time to 9 seconds from 10 seconds). 
Conclusion
Method for determination of particle size distribution of Glimepiride was developed and validated using Laser diffraction technique. Dry dispersion technique was assesses and found that dry dispersion technique is not suitable for and wet dispersion was explored during development trials. Wet dispersant method frozen for determination of particle size distribution of Glimepiride. In method validation, method was found précised with % RSD of 10. .Hence, the method considered as rugged. certain parameters were modified within the allowed range and the results obtained were within the acceptance criteria and % RSD ranges from 6.22% to 21.84% for d(0.1), 3.47% to 9.87for d(0.5) and 4-.69% to 12.85% for d(0.9). It proved method is rugged.
All the analytical data of development and validation has been compiled and found to be satisfactory. Hence, method developed for the particle size method can be suitably used for analysis of Glimepiride active pharmaceutical ingredient. Table 8 : Robustness -6 (Change in sample measurement time to 11 seconds from 10 seconds).
